| Literature DB >> 32707604 |
Francesca Schena1, Federica Penco1, Stefano Volpi1,2, Claudia Pastorino1, Roberta Caorsi3, Francesca Kalli4, Daniela Fenoglio4,5, Annalisa Salis6, Arinna Bertoni1, Ignazia Prigione1, Paola Bocca1, Antonella Insalaco7, Fabrizio De Benedetti7, Francesca Antonini8, Alice Grossi9, Sara Signa1,2, Gianluca Damonte6, Isabella Ceccherini9, Gilberto Filaci4,10, Elisabetta Traggiai11, Marco Gattorno1,3.
Abstract
Adenosine deaminase 2 deficiency (DADA2) is an autoinflammatory disease characterized by inflammatory vasculopathy, early strokes associated often with hypogammaglobulinemia. Pure red cell aplasia, thrombocytopenia, and neutropenia have been reported. The defect is due to biallelic loss of function of ADA2 gene, coding for a protein known to regulate the catabolism of extracellular adenosine. We therefore investigated immune phenotype and B- and T-cell responses in 14 DADA2 patients to address if ADA2 mutation affects B- and T-cell function. Here, we show a significant decrease in memory B cells, in particular class switch memory, and an expansion of CD21low B cells in DADA2 patients. In vitro stimulated B lymphocytes were able to secrete nonfunctional ADA2 protein, suggesting a cell intrinsic defect resulting in an impairment of B-cell proliferation and differentiation. Moreover, CD4+ and CD8+ T cells were diminished; however, the frequency of circulating T follicular helper cells was significantly increased but they had an impairment in IL-21 production possibly contributing to an impaired B cell help. Our findings suggest that ADA2 mutation could lead to a B-cell intrinsic defect but also to a defective Tfh cell function, which could contribute to the immunodeficient phenotype reported in DADA2 patients.Entities:
Keywords: Adenosine deaminase 2; B cell; Follicular helper T cells; Hypogammaglobulinemia; Immunodeficiency
Mesh:
Substances:
Year: 2020 PMID: 32707604 DOI: 10.1002/eji.202048549
Source DB: PubMed Journal: Eur J Immunol ISSN: 0014-2980 Impact factor: 5.532